inSoma Bio

Durham, NC · Founded 2018 · Privately Held (backing)

Developer of bioengineered reconstructive biomaterials designed to enable the use of a person's tissue in surgical procedures. inSoma Bio is based in Durham, NC and was founded in 2018. Its last reported valuation was $18.7 million in May 2024. It has raised $7.8 million across 3 recorded rounds; the latest was a $2.7 million seed round in Sep 2025.

Last reported valuation
$18.7M
Oct 2026
Priced at
—
Total raised
$7.8M
Last round
Seed Round
Sep 2025
What is inSoma Bio worth?
$18.7Mlast reported valuation · Oct 2026

inSoma Bio's last reported valuation, May 2024. Nothing priced has surfaced since.

Free account
More of inSoma Bio with a free account
  • ·The complete investor list: 23 names
  • ·Watch inSoma Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

inSoma Bio funding history

3 rounds
DateRoundRaisedPost-money
Sep 2025Seed Round$2.7M▮
Apr 2023Seed Round$2.7M▮
Aug 2020Seed Round$1.3M▮
Unlock post-money valuations

Membership and data by Private Market View

inSoma Bio valuation

inSoma Bio's last reported valuation was $18.7 million in May 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has inSoma Bio raised?

inSoma Bio has raised $7.8 million across 3 recorded rounds since 2020. The largest was a $2.7 million seed round in Apr 2023; the most recent was a $2.7 million seed round in Sep 2025.

inSoma Bio has filed 10 Form Ds with the SEC since 2020, most recently in May 2024 ($2.7 million sold to 16 investors).

How inSoma Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For inSoma Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about inSoma Bio

What is inSoma Bio worth?
inSoma Bio is valued at $18.7M as of Oct 2026. inSoma Bio's last reported valuation, May 2024. Nothing priced has surfaced since.
How much has inSoma Bio raised?
inSoma Bio has raised $7.8M in total funding across 3 recorded rounds.
When did inSoma Bio last raise?
inSoma Bio last raised in Sep 2025 (Seed Round), raising $2.7M.